EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integration of neuroimaging signatures of aging and Alzheimer's with fluid biomarkers

Mitzi M Gonzales, Ngoc Huynh Ho, David H Wang, Tanweer Rashid, Sachintha R Brandigampala, Mengjin Dong, David Martinez, Sokratis Charisis, Timothy J Hohman, Sudha Seshadri, Christos Davatzikos, Gladys Maestre und 8 weitere

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 17.10.2026. Verfasst von Mitzi M Gonzales und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Aging, Neuroimaging. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Association, Texas Alzheimer's Research and Care Consortium Investigator Grant Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Machine learning algorithms applied to neuroimaging may aid diagnosis and disease monitoring. This study aimed to derive neuroimaging signatures of brain aging (Spatial Pattern of Atrophy for Recognition–Brain Age [SPARE‐BA]) and Alzheimer's disease (SPARE‐AD) in a diverse sample and to examine their associations with plasma biomarkers, diagnosis, and disease progression. METHODS SPARE‐BA and SPARE‐AD were calculated using T1‐images from 1297 participants without dementia. Associations between neuroimaging signatures and plasma biomarkers were assessed with partial correlations. Logistic regression and cox proportional hazard models evaluated diagnostic accuracy and clinical progression. RESULTS SPARE‐AD displayed the strongest association with plasma phosphorylated tau 217, whereas SPARE‐BA correlated most strongly with plasma neurofilament light. The combination of neuroimaging signatures with plasma biomarkers achieved the highest diagnostic discriminability and strongest associations with clinical progression. DISCUSSION Neuroimaging signatures of aging and Alzheimer's disease display distinct associations with plasma biomarkers. Neuroimaging signatures combined with plasma biomarkers may improve the detection and prediction of cognitive impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersAgingNeuroimagingBrainHumansFemaleMaleDisease ProgressionMachine LearningMagnetic Resonance Imagingtau ProteinsAgedNeurofilament ProteinsAged, 80 and overAtrophy

Stichwörter der Autor:innen

Alzheimer's diseasecognitive impairmentdiagnosismachine learningneuroimagingplasma biomarkersprognosis

Substanzen

Biomarkerstau ProteinsNeurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, The University of Texas Health Science Center, San Antonio, Texas, USA.
  • Neuroimage Analytics Laboratory (NAL) and the Biggs Institute Neuroimaging Core (BINC), Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center San Antonio, San An…
  • Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Artificial Intelligence in Biomedical Imaging Laboratory (AIBIL), Center for AI and Data Science for Integrated Diagnostics (AI2D), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, US…

Förderung

  • NIA NIH HHS
  • Alzheimer's Association
  • Texas Alzheimer's Research and Care Consortium Investigator Grant Program
  • DKR Texas Alzheimer's Initiative
  • Texas Council on Alzheimer's Disease and Related Disorders
  • National Institute on Aging

Zitieren

APA

Gonzales, M. M., Ho, N. H., Wang, D. H., Rashid, T., Brandigampala, S. R., Dong, M., Martinez, D., Charisis, S., Hohman, T. J., Seshadri, S., Davatzikos, C., Maestre, G., Kautz, T. F., LaRoche, A., Young, V. M., Sullivan, A. C., Yaffe, K., Toledo, J. B., Alzheimer's Disease Neuroimaging InitiativeHABS‐HD Study Team, & Habes, M. (2026). Integration of neuroimaging signatures of aging and Alzheimer's with fluid biomarkers. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71889

Vancouver

Gonzales MM, Ho NH, Wang DH, Rashid T, Brandigampala SR, Dong M, et al. Integration of neuroimaging signatures of aging and Alzheimer's with fluid biomarkers. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71889

BibTeX
@article{Gonzales2026,
  author = {Gonzales, Mitzi M and Ho, Ngoc Huynh and Wang, David H and Rashid, Tanweer and Brandigampala, Sachintha R and Dong, Mengjin and Martinez, David and Charisis, Sokratis and Hohman, Timothy J and Seshadri, Sudha and Davatzikos, Christos and Maestre, Gladys and Kautz, Tiffany F and LaRoche, Ashley and Young, Vanessa M and Sullivan, Anna Campbell and Yaffe, Kristine and Toledo, Jon B and Alzheimer's Disease Neuroimaging InitiativeHABS‐HD Study Team, Alzheimer's Disease Neuroimaging InitiativeHABS‐HD Study Team and Habes, Mohamad},
  title = {Integration of neuroimaging signatures of aging and Alzheimer's with fluid biomarkers},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71889}
}
Kostenlos starten →